How Weight Loss Can Improve Male Fertility: From Lifestyle Changes to GLP-1 Drugs
Obesity impairs male fertility through hormonal imbalance, inflammation, and lipid stress, with lifestyle changes, bariatric surgery, and GLP-1 drugs showing potential to reverse these effects.
Quick Facts
What This Study Found
Weight loss interventions including lifestyle modification, bariatric surgery, and GLP-1 receptor agonists can improve obesity-related male reproductive dysfunction through multiple mechanisms.
Key Numbers
Reviews lifestyle modification, bariatric surgery, and GLP-1 RA effects on testosterone, semen quality, and reproductive outcomes. Bariatric surgery raises testosterone but may lower sperm count in some men.
How They Did This
Mini-review summarizing current evidence on the impact of weight loss interventions on male fertility outcomes.
Why This Research Matters
Male infertility is increasingly linked to the obesity epidemic. Understanding how different weight loss approaches affect fertility gives men and their doctors more treatment options.
The Bigger Picture
GLP-1 drugs may have an unexpected benefit for men struggling with both obesity and infertility, adding another dimension to the expanding therapeutic profile of these medications.
What This Study Doesn't Tell Us
Mini-review — does not systematically evaluate all available evidence. Most fertility studies are small and observational. Long-term effects of GLP-1 drugs on male fertility are unknown.
Questions This Raises
- ?Do GLP-1 drugs directly improve sperm quality independent of weight loss?
- ?Which weight loss method produces the best fertility outcomes in obese men?
Trust & Context
- Key Stat:
- Obesity impairs sperm quality Hormonal imbalance, inflammation, and lipid stress from obesity reduce semen quality and pregnancy rates, but weight loss interventions can reverse these effects
- Evidence Grade:
- Mini-review of heterogeneous evidence. Weight loss benefits for male fertility are supported by multiple studies but the optimal intervention strategy is not established.
- Study Age:
- Published in 2025, incorporating the latest evidence on GLP-1 drugs and male reproductive health.
- Original Title:
- Managing obesity-related male infertility: insights from weight loss intervention.
- Published In:
- Human reproduction (Oxford, England), 40(11), 2027-2037 (2025)
- Authors:
- Pereira, Thairo A, Thaker, Niral, Rubez, André C, Lima, Victor F N, Bernie, Helen L, Esteves, Sandro C
- Database ID:
- RPEP-13021
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
How does obesity cause male infertility?
Excess fat tissue converts testosterone to estrogen, disrupting the hormonal balance needed for sperm production. Obesity also causes chronic inflammation and oxidative stress that directly damage sperm cells and reduce semen quality.
Can GLP-1 drugs improve male fertility?
Emerging evidence suggests they may, both through weight loss and possibly through direct effects on reproductive hormones. However, this is a new area of research and more studies are needed before making specific recommendations.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13021APA
Pereira, Thairo A; Thaker, Niral; Rubez, André C; Lima, Victor F N; Bernie, Helen L; Esteves, Sandro C. (2025). Managing obesity-related male infertility: insights from weight loss intervention.. Human reproduction (Oxford, England), 40(11), 2027-2037. https://doi.org/10.1093/humrep/deaf180
MLA
Pereira, Thairo A, et al. "Managing obesity-related male infertility: insights from weight loss intervention.." Human reproduction (Oxford, 2025. https://doi.org/10.1093/humrep/deaf180
RethinkPeptides
RethinkPeptides Research Database. "Managing obesity-related male infertility: insights from wei..." RPEP-13021. Retrieved from https://rethinkpeptides.com/research/pereira-2025-managing-obesityrelated-male-infertility
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.